According to Anthony Charles, MD, MPH, of the UNC School of Medicine, the WHO should amend its centralization policy to help doctors save lives in Sub-Saharan Africa.
Unmasking a previously misunderstood gene, University of North Carolina scientists discover an unlikely potential drug target for gastrointestinal cancers.
By focusing on small molecules called microRNAs in stem cells of the intestine, UNC School of Medicine researchers have proposed a new mechanism by which gut microbes might help keep us healthy or make us sick.
UNC's Dr. David Weber and Dr. William Rutala are co-authors of the study, which found that adding UV light to standard cleaning cut transmission of 4 resistant bacteria by 30 percent.
UNC clinical geneticists are part of a national consortium of researchers studying the ins and outs of genome sequencing for newborn health screenings and beyond.
New research led by scientists at the UNC School of Medicine and NC State University demonstrates the effectiveness of using prebiotics to change the composition of the gut microbiome of those suffering from lactose intolerance.
UNC researchers have proven these concerns valid after finding iron deficiency anemia actually protects children against the blood-stage of Plasmodium falciparum malaria in Africa, and treating anemia with iron supplementation removes this protective effect. Morgan Goheen, PhD, is the study's lead author.
In a perspective published in the New England Journal of Medicine, Ethan Basch, MD, MSc, professor of medicine and director of UNC Lineberger’s Cancer Outcomes Research Program, addressed the need for – and the barriers preventing – electronic reporting of patients’ symptoms between visits.
UNC research shows test scores don’t forecast productivity or success in graduate programs within the experimental sciences.
UNC School of Medicine researchers, led by Cindy Wu, MD, used a crowdsourcing model to identify what potential patients value most when seeking an aesthetic surgeon.
UNC scientists conduct seminal experiments to unveil how early-in-life visual experiences – simply trying to see – sculpt a particular subnetwork of brain circuitry we need in order to see properly.
A start-up company co-founded by UNC Lineberger researcher Andrew Wang has raised $2.9 million to commercialize a test designed to capture cancer cells circulating in the blood.
Optogenetics Breakthrough: UNC scientists expand the use of light to control protein activity in cells
The new research technique, developed by researchers at the UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center, has the potential to illuminate the roles of previously inaccessible proteins important for health and disease.
Thomas Caranasos, MD, director, adult cardiac surgery, has collaborated with researchers from N.C. State, as well as Universities in China and Japan, to develop a synthetic cardiac stem cell.
Amanda Nelson, MD, a rheumatologist at the UNC Thurston Arthritis Research Center, has received the “Innovative Research Award” from the Rheumatology Research Foundation. This grant will enable her to study the association between features of osteoarthritis that are observable with ultrasound compared to x-ray observations and symptoms, as well as the potential influence of factors such as age, sex, race, obesity and prior injury.
UNC scientists led by John Sondek, PhD, created a new biochemical tool to block specific types of downstream G-protein signaling, opening new avenues of research and potential drug design and discovery.
This kind of new brain imaging study could help identify cognitive problems and psychiatric disorders very early and develop appropriate interventions.
UNC Lineberger researchers reported at the San Antonio Breast Cancer Symposium they have identified biomarkers they believe can be used as part of a larger model to predict how patients with HER2-positive operative breast cancer will respond to the targeted treatment trastuzumab, commercially known as Herceptin, and chemotherapy.
Less than 50 percent of surveyed teens found it ‘very believable’ that cigars are not a safe alternative to cigarettes, according to a first-of-its-kind UNC School of Medicine study.
By blocking a specific cell signaling pathway in lab animals, researchers reversed signs of chronic immune activation, thereby boosting T-cell recovery and viral suppression.